ラボオートメーションの市場：製品（ロボットアーム、マイクロプレートリーダー、ワークステーション、LIMS、ELN）、用途（創薬、診断、ゲノム、プロテオミクス、微生物）、エンドユーザー（製薬、診断ラボ、科学捜査、環境）、地域別 - 2028年までの世界予測

Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End User (Pharma, Diagnolab, Forensics, Environmental) & Region - Global Forecasts to 2028

世界のラボオートメーション市場は、2022年の51億米ドルから2028年には71億米ドルに達すると予測され、予測期間中のCAGRは5.8％で成長します。ラボオートメーションが提供する利点の増加は、予測期間中の市場成長... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年2月21日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	316	336	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界のラボオートメーション市場は、2022年の51億米ドルから2028年には71億米ドルに達すると予測され、予測期間中のCAGRは5.8％で成長します。ラボオートメーションが提供する利点の増加は、予測期間中の市場成長を促進すると予想される主要な要因の1つです。

"2022年、自動化ワークステーション分野が最大シェアを占める"
製品に基づき、ラボオートメーション市場は、自動ワークステーション、既製自動ワークセル、ソフトウェア、ロボットシステム、自動保管・検索システム、ラボオートメーション機器に区分されます。自動ワークステーション市場はさらに、自動液体処理システム、マイクロプレートリーダー、自動ELISAシステム、自動核酸精製システム手術台などに区分される。2021年の市場シェアは、自動ワークステーション部門が最も大きかった。

"予測期間中、創薬分野が最も高いCAGRを記録すると予測される"
アプリケーションに基づき、市場は創薬、診断、ゲノミクス、プロテオミクス、微生物学、およびその他のアプリケーションに区分されます。アプリケーション別では、創薬分野が予測期間中に最も高いCAGRを占めています。蔓延する疾患とその治療に対する需要の高まりが、このアプリケーションセグメントを牽引する主要因となっています。2020年1月、Eli Lilly and Company（米国）とStrateos, Inc.（米国）は、前者の創薬プロセスを加速させるためにカリフォルニア（米国）に新しいロボット研究所を設立した。また、サーモフィッシャーサイエンティフィックとノースイースタン大学のバイオ医薬品分析トレーニングラボ（BATL）は、個別化医療、モノクローナル抗体、遺伝子・細胞治療などの分野における分析能力の向上とバイオ医薬品業界全体のイノベーションを推進するために、協力協定を締結した。

"バイオテクノロジー＆製薬会社分野は、予測期間中に最も高いCAGRを記録すると予測される"
エンドユーザーに基づき、世界のラボオートメーション市場は、病院＆診断ラボ、バイオテクノロジー＆製薬会社、研究＆学術機関、法医学ラボ、環境＆試験ラボ、食品＆飲料業界に区分されます。エンドユーザー別では、バイオテクノロジー＆製薬会社分野が予測期間中に最も高いCAGRを記録すると予測されています。製薬会社における新薬や効果的な薬の開発に対するプレッシャーの高まりにより、ラボのプロセスを自動化し、研究者がルーチンワークや反復作業に費やす時間を短縮することへの需要が高まっています。このプロセスにラボの自動化を採用することで、偽陽性や偽陰性を減らすことで検査のスピードと精度が向上し、医薬品開発にかかる時間とコストを削減することができます。

"2022年、北米地域の市場がラボオートメーションの大きな市場シェアを占めると予想される"
ラボオートメーション市場は、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東・アフリカの5つの主要地域をカバーしています。北米地域の市場は、2022年にラボオートメーションの重要な市場シェアを占めると予想されています。同地域では、医療施設の普及率の高さや健康意識の高まりから、診断検査も増加傾向にあります。高齢者人口の増加や生活習慣病の流行に伴い、診断薬や治療薬の需要も大幅に増加しています。このような需要に対応するため、診断ラボや研究センターではラボオートメーションソリューションの導入が進んでいます。

本レポートで参照した主な参加者の内訳は以下のとおりです：
- 企業タイプ別ティア1-48％、ティア2-36％、ティア3-16％：ティア1-48％、ティア2-36％、ティア3-16％。
- 役職別Cレベル-10％、ディレクターレベル-14％、その他-76
- 地域別北米40％、欧州32％、アジア太平洋20％、中南米5％、中近東・アフリカ3％。

ラボオートメーション市場の著名なプレーヤーは、Thermo Fisher Scientific（米国）、Tecan Group（スイス）、Danaher Corporation（米国）、Agilent Technologies（米国）、F．Hoffmann-La Roche（スイス）、PerkinElmer（米国）、Eppendorf（ドイツ）、Becton, Dickinson and Company（米国）、Waters Corporation（米国）、Siemens Healthineers（ドイツ）、Abbott Laboratories（米国）、bioMérieux（フランス）、Endress+Hauser Group（スイス）、Hamilton Company（米国）、Gilson（米国）、BMG Labtech（ドイツ）、Aurora Biomed（カナダ）、Peak Analysis & Automation（英国）、Formulatrix（米国）、QIAGEN（ドイツ）、Hudson Robotics（米国）など、多数。
調査対象
本レポートでは、ラボオートメーション市場を製品、用途、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーのための競争環境の詳細を提供します。さらに、ミクロ市場を個々の成長動向に関して分析し、主要5地域（およびこれらの地域のそれぞれの国）に関して、市場セグメントの収益を予測しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握することができ、ひいてはより大きな市場シェアを獲得するのに役立ちます。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場でのプレゼンスを強化することができます。

本レポートでは、以下のポイントについて考察しています：
- 市場の浸透度：ラボオートメーション市場のトッププレーヤーが提供する製品ポートフォリオに関する包括的な情報
- 製品開発/イノベーション：ラボオートメーション市場における今後の動向、研究開発活動、製品発表に関する詳細な洞察
- 市場開拓：有利な新興地域に関する包括的な情報
- 市場の多様化：ラボオートメーション市場の新製品、成長地域、最新動向に関する詳細な情報
- 競合他社の評価：主要市場プレイヤーの市場セグメント、成長戦略、収益分析、製品に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS AND EXCLUSIONS 41
1.3 MARKETS COVERED 42
FIGURE 1 MARKET SEGMENTATION 42
FIGURE 2 GEOGRAPHIC SEGMENTATION 43
FIGURE 3 YEARS CONSIDERED 43
1.4 CURRENCY 43
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 4 RESEARCH APPROACH 46
2.2 RECESSION IMPACT 47
2.3 RESEARCH DESIGN 48
FIGURE 5 LABORATORY AUTOMATION MARKET: RESEARCH DESIGN METHODOLOGY 48
2.3.1 SECONDARY RESEARCH 48
2.3.2 PRIMARY RESEARCH 49
2.3.2.1 Primary sources 50
2.3.2.2 Key industry insights 51
2.3.2.3 Breakdown of primaries 51
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 51
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 52
2.4 MARKET SIZE ESTIMATION 52
FIGURE 8 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 53
2.4.1 BOTTOM-UP APPROACH 53
2.4.1.1 Approach 1: Company revenue estimation 54
2.4.1.2 Approach 2: Customer-based market estimation 54
FIGURE 9 LAB AUTOMATION MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 54
2.4.1.3 CAGR projection 55
FIGURE 10 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 55
2.5 DATA VALIDATION APPROACH 56
FIGURE 11 DATA TRIANGULATION METHODOLOGY 56
2.6 MARKET SHARE ASSESSMENT 57
2.7 STUDY ASSUMPTIONS 57
2.8 RISK ASSESSMENT 57
2.8.1 LAB AUTOMATION MARKET: RISK ASSESSMENT 57
2.9 GROWTH RATE ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
FIGURE 12 LAB AUTOMATION MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION) 59
FIGURE 13 LAB AUTOMATION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 60
FIGURE 14 LAB AUTOMATION MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 60
FIGURE 15 GEOGRAPHICAL SNAPSHOT: LAB AUTOMATION MARKET 61
4 PREMIUM INSIGHTS 63
4.1 LAB AUTOMATION MARKET OVERVIEW 63
FIGURE 16 INCREASING RESEARCH ACTIVITIES BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH 63
4.2 NORTH AMERICA: LAB AUTOMATION MARKET, BY PRODUCT 64
FIGURE 17 AUTOMATED WORKSTATIONS TO DOMINATE MARKET DURING FORECAST PERIOD 64
4.3 ASIA PACIFIC: LAB AUTOMATION MARKET, BY END USER 65
FIGURE 18 HOSPITAL & DIAGNOSTIC LABORATORIES TO CONTINUE TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD 65
4.4 GEOGRAPHIC SNAPSHOT OF LAB AUTOMATION MARKET 66
FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
FIGURE 20 LAB AUTOMATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
5.2.1 DRIVERS 68
5.2.1.1 Technological advancements and increasing R&D investments 68
FIGURE 21 R&D SPENDING (TOTAL % OF GDP), 2020 68
TABLE 1 R&D INVESTMENTS, BY COUNTRY 69
5.2.1.2 Growing demand for process automation for food safety 69
5.2.1.3 Standardization of workflows 70
5.2.1.4 Stringent regulatory control in healthcare industry 70
5.2.2 RESTRAINTS 71
5.2.2.1 Slow adoption of automation by small and medium-sized laboratories 71
5.2.2.2 Long gestation period for workflow implementation 71
5.2.3 OPPORTUNITIES 71
5.2.3.1 Improving healthcare infrastructure across emerging countries 71
5.2.3.2 Growth in pharmaceutical and biotechnology industries 72

5.2.4 CHALLENGES 73
5.2.4.1 Limited feasibility with technology integration in analytical labs 73
5.2.4.2 Availability of refurbished lab automation equipment 73
5.3 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 2 LAB AUTOMATION MARKET: PORTER’S FIVE FORCES ANALYSIS 73
5.3.1 THREAT FROM NEW ENTRANTS 73
5.3.2 THREAT FROM SUBSTITUTES 74
5.3.3 BARGAINING POWER OF SUPPLIERS 74
5.3.4 BARGAINING POWER OF BUYERS 74
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.4 VALUE CHAIN ANALYSIS 74
5.4.1 RESEARCH & DEVELOPMENT 74
5.4.2 PROCUREMENT & PRODUCT DEVELOPMENT 75
5.4.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES 75
FIGURE 22 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 75
5.5 SUPPLY CHAIN ANALYSIS 76
5.5.1 PROMINENT COMPANIES 76
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES 76
5.5.3 END USERS 76
TABLE 3 SUPPLY CHAIN ECOSYSTEM 76
FIGURE 23 SUPPLY CHAIN ANALYSIS 77
5.6 ECOSYSTEM COVERAGE FOR ANALYTICAL INSTRUMENTATION 77
FIGURE 24 ECOSYSTEM COVERAGE 77
5.7 PATENT ANALYSIS 78
FIGURE 25 PATENT DETAILS FOR LAB AUTOMATION (JANUARY 2012–OCTOBER 2022) 78
FIGURE 26 PATENT DETAILS FOR AUTOMATED WORKSTATIONS (JANUARY 2012–OCTOBER 2022) 79
FIGURE 27 PATENT DETAILS FOR LAB AUTOMATION SOFTWARE (JANUARY 2013–JANUARY 2023) 80
FIGURE 28 PATENT DETAILS FOR AUTOMATED STORAGE & RETRIEVAL SYSTEMS (JANUARY 2012–OCTOBER 2022) 81
5.8 TRADE ANALYSIS 82
5.8.1 TRADE ANALYSIS: LAB AUTOMATION 82
TABLE 4 IMPORT DATA FOR LAB AUTOMATION (HS CODE 8419), BY COUNTRY, 2017–2021 (USD) 82
TABLE 5 EXPORT DATA FOR LAB AUTOMATION (HS CODE 8491), BY COUNTRY, 2017–2021 (USD) 82
5.9 KEY CONFERENCES & EVENTS (2023–2024) 83
TABLE 6 LAB AUTOMATION MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS 83
5.10 TECHNOLOGY ANALYSIS 84

5.11 CASE STUDY ANALYSIS 85
5.11.1 TECHNOLOGICAL CHALLENGES 85
TABLE 7 CASE 1: CHALLENGES FACED WHILE IMPLEMENTING NEW TECHNOLOGIES 85
5.11.2 INCREASING SALES MODELS 85
TABLE 8 CASE 2: DEPENDENCE ON CONTRACT MANUFACTURING AND OUTSOURCING 85
5.12 PRICING ANALYSIS 86
TABLE 9 PRICING TREND ANALYSIS 86
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 86
FIGURE 29 CURRENT AND FUTURE REVENUE OPPORTUNITY POCKETS 86
6 LAB AUTOMATION MARKET, BY PRODUCT 87
6.1 INTRODUCTION 88
TABLE 10 LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 88
6.2 AUTOMATED WORKSTATIONS 88
TABLE 11 LAB AUTOMATION MARKET FOR AUTOMATED WORKSTATIONS, BY TYPE, 2020–2028 (USD MILLION) 89
TABLE 12 LAB AUTOMATION MARKET FOR AUTOMATED WORKSTATIONS, BY REGION, 2020–2028 (USD MILLION) 89
TABLE 13 LAB AUTOMATION MARKET FOR AUTOMATED WORKSTATIONS, BY APPLICATION, 2020–2028 (USD MILLION) 90
TABLE 14 LAB AUTOMATION MARKET FOR AUTOMATED WORKSTATIONS, BY END USER, 2020–2028 (USD MILLION) 90
6.2.1 AUTOMATED LIQUID HANDLING SYSTEMS 91
TABLE 15 AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2020–2028 (USD MILLION) 91
TABLE 16 AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 92
TABLE 17 LAB AUTOMATION MARKET FOR AUTOMATED LIQUID HANDLING SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 92
TABLE 18 LAB AUTOMATION MARKET FOR AUTOMATED LIQUID HANDLING SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 93
6.2.1.1 Automated integrated workstations 93
6.2.1.1.1 Availability of workstations in several configurations to drive demand 93
TABLE 19 LAB AUTOMATION MARKET FOR AUTOMATED INTEGRATED WORKSTATIONS, BY REGION, 2020–2028 (USD MILLION) 94
6.2.1.2 Pipetting systems 94
6.2.1.2.1 Benefits such as increased throughput, greater accuracy, and better workflow to boost market 94
TABLE 20 LAB AUTOMATION MARKET FOR PIPETTING SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 95
6.2.1.3 Reagent dispensers 95
6.2.1.3.1 Accuracy, reproducibility, and reduced risk of contamination to contribute to demand for reagent dispensers 95
TABLE 21 LAB AUTOMATION MARKET FOR REAGENT DISPENSERS, BY REGION, 2020–2028 (USD MILLION) 96
6.2.1.4 Microplate washers 96
6.2.1.4.1 Ability of microplate washers to reduce possibility of reagent contamination to fuel adoption 96
TABLE 22 LAB AUTOMATION MARKET FOR MICROPLATE WASHERS, BY REGION, 2020–2028 (USD MILLION) 97
6.2.2 MICROPLATE READERS 97
TABLE 23 LAB AUTOMATION MARKET FOR MICROPLATE READERS, BY REGION, 2020–2028 (USD MILLION) 98
TABLE 24 LAB AUTOMATION MARKET FOR MICROPLATE READERS, BY TYPE, 2020–2028 (USD MILLION) 98
TABLE 25 LAB AUTOMATION MARKET FOR MICROPLATE READERS, BY APPLICATION, 2020–2028 (USD MILLION) 99
TABLE 26 LAB AUTOMATION MARKET FOR MICROPLATE READERS, BY END USER, 2020–2028 (USD MILLION) 99
6.2.2.1 Multi-mode microplate readers 100
TABLE 27 LAB AUTOMATION MARKET FOR MULTI-MODE MICROPLATE READERS, BY TYPE, 2020–2028 (USD MILLION) 100
TABLE 28 LAB AUTOMATION MARKET FOR MULTI-MODE MICROPLATE READERS, BY REGION, 2020–2028 (USD MILLION) 101
6.2.2.1.1 Filter-based readers 101
6.2.2.1.1.1 Cost-effective and sensitive nature of filter-based readers to drive market 101
TABLE 29 LAB AUTOMATION MARKET FOR FILTER-BASED READERS, BY REGION, 2020–2028 (USD MILLION) 102
6.2.2.1.2 Monochromator-based readers 102
6.2.2.1.2.1 Ability to run spectral scans to characterize new fluorophores or study spectral shifts in some assays to boost market 102
TABLE 30 LAB AUTOMATION MARKET FOR MONOCHROMATOR-BASED READERS, BY REGION, 2020–2028 (USD MILLION) 103
6.2.2.1.3 Hybrid readers 103
6.2.2.1.3.1 High flexibility, sensitivity, and convenience of hybrid readers to contribute to growth 103
TABLE 31 LAB AUTOMATION MARKET FOR HYBRID READERS, BY REGION, 2020–2028 (USD MILLION) 103
6.2.2.2 Single-mode microplate readers 104
TABLE 32 LAB AUTOMATION MARKET FOR SINGLE-MODE MICROPLATE READERS, BY TYPE, 2020–2028 (USD MILLION) 104
TABLE 33 LAB AUTOMATION MARKET FOR SINGLE-MODE MICROPLATE READERS, BY REGION, 2020–2028 (USD MILLION) 104
6.2.2.2.1 Fluorescence readers 105
6.2.2.2.1.1 Better sensitivity and application range than absorbance readers to boost market 105
TABLE 34 LAB AUTOMATION MARKET FOR FLUORESCENCE READERS, BY REGION, 2020–2028 (USD MILLION) 105
6.2.2.2.2 Absorbance readers 105
6.2.2.2.2.1 Ability of absorbance readers to gather data on biological or chemical features of test substances to favor market growth 105
TABLE 35 LAB AUTOMATION MARKET FOR ABSORBANCE READERS, BY REGION, 2020–2028 (USD MILLION) 106
6.2.2.2.3 Luminescence readers 106
6.2.2.2.3.1 Ability of luminescence readers to provide broader dynamic range and greater sensitivity to propel market 106
TABLE 36 LAB AUTOMATION MARKET FOR LUMINESCENCE READERS, BY REGION, 2020–2028 (USD MILLION) 107
6.2.3 AUTOMATED ELISA SYSTEMS 107
6.2.3.1 Wide use of automated ELISA systems in research, food testing, diagnostics, and other industrial applications to drive market growth 107
TABLE 37 LAB AUTOMATION MARKET FOR AUTOMATED ELISA SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 108
TABLE 38 LAB AUTOMATION MARKET FOR AUTOMATED ELISA SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 108
TABLE 39 LAB AUTOMATION MARKET FOR AUTOMATED ELISA SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 109
6.2.4 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS 109
6.2.4.1 Technological advancements and growing market for genomics to drive demand for automated nucleic acid purification systems 109
TABLE 40 LAB AUTOMATION MARKET FOR AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 110
TABLE 41 LAB AUTOMATION MARKET FOR AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 110
TABLE 42 LAB AUTOMATION MARKET FOR AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 111
6.3 OFF-THE-SHELF AUTOMATED WORK CELLS 111
TABLE 43 LAB AUTOMATION MARKET FOR OFF-THE-SHELF AUTOMATED WORK CELLS, BY TYPE, 2020–2028 (USD MILLION) 112
TABLE 44 LAB AUTOMATION MARKET FOR OFF-THE-SHELF AUTOMATED WORK CELLS, BY REGION, 2020–2028 (USD MILLION) 112
TABLE 45 LAB AUTOMATION MARKET FOR OFF-THE-SHELF AUTOMATED WORK CELLS, BY APPLICATION, 2020–2028 (USD MILLION) 113
TABLE 46 LAB AUTOMATION MARKET FOR OFF-THE-SHELF AUTOMATED WORK CELLS, BY END USER, 2020–2028 (USD MILLION) 113
6.3.1 PRE-ANALYTICAL AUTOMATION 114
6.3.1.1 Potential demand for automation in clinical labs to drive market 114
TABLE 47 LAB AUTOMATION MARKET FOR PRE-ANALYTICAL AUTOMATION, BY REGION, 2020–2028 (USD MILLION) 114
TABLE 48 LAB AUTOMATION MARKET FOR PRE-ANALYTICAL AUTOMATION, BY APPLICATION, 2020–2028 (USD MILLION) 115
TABLE 49 LAB AUTOMATION MARKET FOR PRE-ANALYTICAL AUTOMATION, BY END USER, 2020–2028 (USD MILLION) 115
6.3.2 POST-ANALYTICAL AUTOMATION 116
6.3.2.1 Growing geriatric population and addition of new tests in labs to propel market growth 116
TABLE 50 LAB AUTOMATION MARKET FOR POST-ANALYTICAL AUTOMATION, BY REGION, 2020–2028 (USD MILLION) 116
TABLE 51 LAB AUTOMATION MARKET FOR POST-ANALYTICAL AUTOMATION, BY APPLICATION, 2020–2028 (USD MILLION) 117
TABLE 52 LAB AUTOMATION MARKET FOR POST-ANALYTICAL AUTOMATION, BY END USER, 2020–2028 (USD MILLION) 117
6.3.3 TOTAL LAB AUTOMATION 118
6.3.3.1 Challenges in implementing TLA in most labs to restrict market growth 118
TABLE 53 LAB AUTOMATION MARKET FOR TLA, BY REGION, 2020–2028 (USD MILLION) 118
TABLE 54 LAB AUTOMATION MARKET FOR TLA, BY APPLICATION, 2020–2028 (USD MILLION) 119
TABLE 55 LAB AUTOMATION MARKET FOR TLA, BY END USER, 2020–2028 (USD MILLION) 119
6.4 SOFTWARE 120
TABLE 56 LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 120
TABLE 57 LAB AUTOMATION SOFTWARE MARKET, BY REGION, 2020–2028 (USD MILLION) 120
TABLE 58 LAB AUTOMATION SOFTWARE MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 121
TABLE 59 LAB AUTOMATION SOFTWARE MARKET, BY END USER, 2020–2028 (USD MILLION) 121
6.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEMS 122
6.4.1.1 Increasing need to manage larger volumes of data to drive market 122
TABLE 60 LAB AUTOMATION MARKET FOR LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 123
TABLE 61 LAB AUTOMATION MARKET FOR LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 123
TABLE 62 LAB AUTOMATION MARKET FOR LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 124
6.4.2 ELECTRONIC LABORATORY NOTEBOOKS 124
6.4.2.1 Need for compliance with regulations, IP protection, and instrument management to support growth 124
TABLE 63 LAB AUTOMATION MARKET FOR ELECTRONIC LABORATORY NOTEBOOKS, BY REGION, 2020–2028 (USD MILLION) 125
TABLE 64 LAB AUTOMATION MARKET FOR ELECTRONIC LABORATORY NOTEBOOKS, BY APPLICATION, 2020–2028 (USD MILLION) 125
TABLE 65 LAB AUTOMATION MARKET FOR ELECTRONIC LABORATORY NOTEBOOKS, BY END USER, 2020–2028 (USD MILLION) 126
6.4.3 LABORATORY EXECUTION SYSTEMS 126
6.4.3.1 Paperless, high-productivity environment provided by LES to drive market 126
TABLE 66 LAB AUTOMATION MARKET FOR LABORATORY EXECUTION SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 127
TABLE 67 LAB AUTOMATION MARKET FOR LABORATORY EXECUTION SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 127
TABLE 68 LAB AUTOMATION MARKET FOR LABORATORY EXECUTION SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 128
6.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS 128
6.4.4.1 Need to collect and manage large data volumes to fuel demand for SDMS 128
TABLE 69 LAB AUTOMATION MARKET FOR SCIENTIFIC DATA MANAGEMENT SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 129
TABLE 70 LAB AUTOMATION MARKET FOR SCIENTIFIC DATA MANAGEMENT SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 129
TABLE 71 LAB AUTOMATION MARKET FOR SCIENTIFIC DATA MANAGEMENT SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 130
6.5 ROBOTIC SYSTEMS 130
TABLE 72 LAB AUTOMATION MARKET FOR ROBOTIC SYSTEMS, BY TYPE, 2020–2028 (USD MILLION) 131
TABLE 73 LAB AUTOMATION MARKET FOR ROBOTIC SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 131
TABLE 74 LAB AUTOMATION MARKET FOR ROBOTIC SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 132
TABLE 75 LAB AUTOMATION MARKET FOR ROBOTIC SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 132
6.5.1 ROBOTIC ARMS 133
6.5.1.1 Flexibility, ease of use, and space efficiency to drive use of robotic arms 133
TABLE 76 LAB AUTOMATION MARKET FOR ROBOTIC ARMS, BY REGION, 2020–2028 (USD MILLION) 133
TABLE 77 LAB AUTOMATION MARKET FOR ROBOTIC ARMS, BY APPLICATION, 2020–2028 (USD MILLION) 134
TABLE 78 LAB AUTOMATION MARKET FOR ROBOTIC ARMS, BY END USER, 2020–2028 (USD MILLION) 134
6.5.2 TRACK ROBOTS 135
6.5.2.1 Ability to boost walkaway time for lab personnel and raise throughput to drive demand for track robots 135
TABLE 79 LAB AUTOMATION MARKET FOR TRACK ROBOTS, BY REGION, 2020–2028 (USD MILLION) 135
TABLE 80 LAB AUTOMATION MARKET FOR TRACK ROBOTS, BY APPLICATION, 2020–2028 (USD MILLION) 135
TABLE 81 LAB AUTOMATION MARKET FOR TRACK ROBOTS, BY END USER, 2020–2028 (USD MILLION) 136
6.6 AUTOMATED STORAGE & RETRIEVAL SYSTEMS 136
6.6.1 NEED TO HOLD SPECIMENS AT SET TEMPERATURES TO DRIVE DEMAND GROWTH 136
TABLE 82 LAB AUTOMATION MARKET FOR AUTOMATED STORAGE & RETRIEVAL SYSTEMS, BY REGION, 2020–2028 (USD MILLION) 137
TABLE 83 LAB AUTOMATION MARKET FOR AUTOMATED STORAGE & RETRIEVAL SYSTEMS, BY APPLICATION, 2020–2028 (USD MILLION) 137
TABLE 84 LAB AUTOMATION MARKET FOR AUTOMATED STORAGE & RETRIEVAL SYSTEMS, BY END USER, 2020–2028 (USD MILLION) 138
6.7 OTHER LAB AUTOMATION EQUIPMENT 138
TABLE 85 LAB AUTOMATION MARKET FOR OTHER LAB AUTOMATION EQUIPMENT, BY REGION, 2020–2028 (USD MILLION) 138
TABLE 86 LAB AUTOMATION MARKET FOR OTHER LAB AUTOMATION EQUIPMENT, BY APPLICATION, 2020–2028 (USD MILLION) 139
TABLE 87 LAB AUTOMATION MARKET FOR OTHER LAB AUTOMATION EQUIPMENT, BY END USER, 2020–2028 (USD MILLION) 139
7 LAB AUTOMATION MARKET, BY APPLICATION 140
7.1 INTRODUCTION 141
TABLE 88 LAB AUTOMATION MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 141
7.2 DRUG DISCOVERY 141
TABLE 89 LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2020–2028 (USD MILLION) 142
TABLE 90 LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2028 (USD MILLION) 143
7.2.1 HIGH-THROUGHPUT SCREENING 143
7.2.1.1 Ability of automated HTS to screen large numbers of candidates in short durations of time to drive growth 143
TABLE 91 LAB AUTOMATION MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2020–2028 (USD MILLION) 144
7.2.2 COMPOUND MANAGEMENT 144
7.2.2.1 Importance of compound management in drug discovery to boost market 144
TABLE 92 LAB AUTOMATION MARKET FOR COMPOUND MANAGEMENT, BY REGION, 2020–2028 (USD MILLION) 145
7.2.3 ADME SCREENING 145
7.2.3.1 Growing need for companies to reduce costs and late-stage drug failure to drive demand for ADME screening 145
TABLE 93 LAB AUTOMATION MARKET FOR ADME SCREENING, BY REGION, 2020–2028 (USD MILLION) 146
7.2.4 COMPOUND WEIGHING & DISSOLUTION 146
7.2.4.1 Ability of automation to balance and weigh hundreds of samples without user intervention to propel growth 146
TABLE 94 LAB AUTOMATION MARKET FOR COMPOUND WEIGHING & DISSOLUTION, BY REGION, 2020–2028 (USD MILLION) 147
7.2.5 OTHER DRUG DISCOVERY APPLICATIONS 147
TABLE 95 LAB AUTOMATION MARKET FOR OTHER DRUG DISCOVERY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 147
7.3 DIAGNOSTICS 148
TABLE 96 LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2028 (USD MILLION) 148
TABLE 97 LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY REGION, 2020–2028 (USD MILLION) 149
7.3.1 PRE-ANALYTICS/SAMPLE PREPARATION 149
7.3.1.1 Importance and labor-intensive nature of pre-analytics/sample preparation to boost use of automated instruments 149
TABLE 98 LAB AUTOMATION MARKET FOR PRE-ANALYTICS/SAMPLE PREPARATION, BY REGION, 2020–2028 (USD MILLION) 149
7.3.2 ENZYME IMMUNOASSAYS 150
7.3.2.1 Rising disease burden and increasing testing volumes to drive demand for automation 150
TABLE 99 LAB AUTOMATION MARKET FOR ENZYME IMMUNOASSAYS, BY REGION, 2020–2028 (USD MILLION) 150
7.3.3 SAMPLE DISTRIBUTION, SPLITTING, AND ARCHIVING 150
7.3.3.1 Ease of monitoring interactions and need for reduced tube manipulation to drive use of automation 150
TABLE 100 LAB AUTOMATION MARKET FOR SAMPLE DISTRIBUTION, SPLITTING, AND ARCHIVING, BY REGION, 2020–2028 (USD MILLION) 151
7.4 GENOMICS 151
7.4.1 GROWING RESEARCH ACTIVITIES AND AVAILABILITY OF PUBLIC-PRIVATE FUNDING TO DRIVE GROWTH 151
TABLE 101 LAB AUTOMATION MARKET FOR GENOMICS, BY REGION, 2020–2028 (USD MILLION) 152
7.5 PROTEOMICS 152
7.5.1 NEED FOR ROBOTICS TO REDUCE COMPLEXITIES OF PROTEOME DATASETS TO BOOST GROWTH 152
TABLE 102 LAB AUTOMATION MARKET FOR PROTEOMICS, BY REGION, 2020–2028 (USD MILLION) 153
7.6 MICROBIOLOGY 153
7.6.1 POOR TAT AND INCREASING SPECIMEN VOLUMES TO SUPPORT DEMAND FOR AUTOMATION IN MICROBIOLOGY WORKFLOWS 153
TABLE 103 LAB AUTOMATION MARKET FOR MICROBIOLOGY, BY REGION, 2020–2028 (USD MILLION) 154
7.7 OTHER APPLICATIONS 154
TABLE 104 LAB AUTOMATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 154
8 LAB AUTOMATION MARKET, BY END USER 155
8.1 INTRODUCTION 156
TABLE 105 LAB AUTOMATION MARKET, BY END USER, 2020–2028 (USD MILLION) 156
8.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 157
8.2.1 BIOTECH & PHARMA COMPANIES TO DOMINATE MARKET FOR LAB AUTOMATION 157
TABLE 106 LAB AUTOMATION MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2020–2028 (USD MILLION) 158
8.3 HOSPITAL & DIAGNOSTIC LABORATORIES 158
8.3.1 GROWING GERIATRIC POPULATION AND CLINICAL VOLUMES TO SUPPORT MARKET GROWTH 158
TABLE 107 LAB AUTOMATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2020–2028 (USD MILLION) 159
8.4 RESEARCH & ACADEMIC INSTITUTES 159
8.4.1 RISING BIOTECHNOLOGY AND LIFE SCIENCE RESEARCH TO DRIVE DEMAND FOR HIGH-END INSTRUMENTS 159
TABLE 108 LAB AUTOMATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2020–2028 (USD MILLION) 160
8.5 ENVIRONMENTAL TESTING LABORATORIES 160
8.5.1 INCREASING POLLUTION CONTROL GUIDELINES TO DRIVE DEMAND FOR ENVIRONMENTAL TESTING 160
TABLE 109 LAB AUTOMATION MARKET FOR ENVIRONMENTAL TESTING LABORATORIES, BY REGION, 2020–2028 (USD MILLION) 161
8.6 FORENSIC LABORATORIES 161
8.6.1 INCREASING FUNDING TO BOOST MARKET 161
TABLE 110 LAB AUTOMATION MARKET FOR FORENSIC LABORATORIES, BY REGION, 2020–2028 (USD MILLION) 162
8.7 FOOD & BEVERAGE INDUSTRY 162
8.7.1 INCREASING DEMAND FOR FOOD PRODUCTS AND RISING SAFETY REGULATIONS TO DRIVE SEGMENT 162
TABLE 111 LAB AUTOMATION MARKET FOR FOOD & BEVERAGE INDUSTRY, BY REGION, 2020–2028 (USD MILLION) 163
9 LAB AUTOMATION MARKET, BY REGION 164
9.1 INTRODUCTION 165
TABLE 112 LAB AUTOMATION MARKET, BY REGION, 2020–2028 (USD MILLION) 165
9.2 NORTH AMERICA 165
FIGURE 30 NORTH AMERICA: LAB AUTOMATION MARKET SNAPSHOT 166
TABLE 113 NORTH AMERICA: LAB AUTOMATION MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 167
TABLE 114 NORTH AMERICA: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 167
TABLE 115 NORTH AMERICA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 168
TABLE 116 NORTH AMERICA: AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 168
TABLE 117 NORTH AMERICA: AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2020–2028 (USD MILLION) 169
TABLE 118 NORTH AMERICA: MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2020–2028 (USD MILLION) 169
TABLE 119 NORTH AMERICA: SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2020–2028 (USD MILLION) 170
TABLE 120 NORTH AMERICA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 170
TABLE 121 NORTH AMERICA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 170
TABLE 122 NORTH AMERICA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 171
TABLE 123 NORTH AMERICA: LAB AUTOMATION MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 171
TABLE 124 NORTH AMERICA: LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2020–2028 (USD MILLION) 172
TABLE 125 NORTH AMERICA: LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2028 (USD MILLION) 172
TABLE 126 NORTH AMERICA: LAB AUTOMATION MARKET, BY END USER, 2020–2028 (USD MILLION) 173
9.2.1 US 173
9.2.1.1 Large number of major pharma-biotech companies in country to boost growth 173
TABLE 127 US: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 174
TABLE 128 US: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 174
TABLE 129 US: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 175
TABLE 130 US: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 175
TABLE 131 US: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 175
9.2.2 CANADA 176
9.2.2.1 Increasing investments in genomics and research facilities to increase adoption of lab automation 176
TABLE 132 CANADA: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 176
TABLE 133 CANADA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 177
TABLE 134 CANADA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 177
TABLE 135 CANADA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 177
TABLE 136 CANADA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 178
9.3 EUROPE 178
TABLE 137 EUROPE: LAB AUTOMATION MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 179
TABLE 138 EUROPE: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 179
TABLE 139 EUROPE: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 180
TABLE 140 EUROPE: AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 180
TABLE 141 EUROPE: AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2020–2028 (USD MILLION) 181
TABLE 142 EUROPE: MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2020–2028 (USD MILLION) 181
TABLE 143 EUROPE: SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2020–2028 (USD MILLION) 181
TABLE 144 EUROPE: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 182
TABLE 145 EUROPE: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 182
TABLE 146 EUROPE: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 182
TABLE 147 EUROPE: LAB AUTOMATION MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 183
TABLE 148 EUROPE: LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2020–2028 (USD MILLION) 183
TABLE 149 EUROPE: LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2028 (USD MILLION) 184
TABLE 150 EUROPE: LAB AUTOMATION MARKET, BY END USER, 2020–2028 (USD MILLION) 184
9.3.1 GERMANY 185
9.3.1.1 Funding for biomedical and technical research likely to drive market in Germany 185
TABLE 151 GERMANY: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 185
TABLE 152 GERMANY: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 186
TABLE 153 GERMANY: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 186
TABLE 154 GERMANY: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 186
TABLE 155 GERMANY: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 187
9.3.2 FRANCE 187
9.3.2.1 Increasing investments by pharma and biotech companies to drive market growth 187
TABLE 156 FRANCE: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 188
TABLE 157 FRANCE: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 188
TABLE 158 FRANCE: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 189
TABLE 159 FRANCE: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 189
TABLE 160 FRANCE: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 189
9.3.3 UK 190
9.3.3.1 Rising investments and clinical trial activities to favor market growth 190
TABLE 161 UK: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 190
TABLE 162 UK: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 191
TABLE 163 UK: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 191
TABLE 164 UK: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 191
TABLE 165 UK: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 192
9.3.4 ITALY 192
9.3.4.1 Advancements in biotechnology and increasing R&D investments by pharmaceutical companies to fuel market growth 192
TABLE 166 ITALY: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 193
TABLE 167 ITALY: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 193
TABLE 168 ITALY: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 194
TABLE 169 ITALY: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 194
TABLE 170 ITALY: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 194

9.3.5 SPAIN 195
9.3.5.1 Increasing clinical trials and availability of funding to enhance research in country 195
TABLE 171 SPAIN: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 196
TABLE 172 SPAIN: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 196
TABLE 173 SPAIN: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 197
TABLE 174 SPAIN: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 197
TABLE 175 SPAIN: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 197
9.3.6 REST OF EUROPE 198
TABLE 176 REST OF EUROPE: LAB AUTOMATION MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 198
TABLE 177 REST OF EUROPE: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2020–2028 (USD MILLION) 199
TABLE 178 REST OF EUROPE: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2020–2028 (USD MILLION) 199
TABLE 179 REST OF EUROPE: ROBOTIC SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 199
TABLE 180 REST OF EUROPE: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2020–2028 (USD MILLION) 200

ページTOPに戻る

Table of Contents

Summary

The global lab automation market is projected to reach USD 7.1 billion by 2028 from USD 5.1 billion in 2022, growing at a CAGR of 5.8% during the forecast period. The rise in advantages offered by lab automation is one of the major factors anticipated to boost market growth in the forecasting years.

“The automated workstation segment to hold the largest share of the market in 2022”
Based on the product, the lab automation market is segmented into automated workstations, off-the-shelf automated work cells, software, robotic systems, automated storage & retrieval systems, and lab automation equipment. The automated workstation market is further segmented into automated liquid handling systems, microplate readers, automated ELISA systems, and automated nucleic acid purification system surgical table. The automated workstations segment accounted for the largest market share in 2021.

“The drug discovery segment is projected to register the highest CAGR during the forecast period”
Based on application, the market is segmented as drug discovery, diagnostics, genomics, proteomics, microbiology, and other applications. By application, drug discovery segment has accounted for the highest CAGR during the forecast period. The prevailing diseases and the growing demand of their treatments had been the key factor driving for this application segment. In January 2020, Eli Lilly and Company (US) and Strateos, Inc. (US) set up a new robotic laboratory in California (US) to accelerate the former’s drug discovery process. Thermo Fisher Scientific and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University also entered into a collaborative agreement in a bid to advance analytical capabilities and drive innovation across the biopharmaceutical industry in areas such as personalized medicine, monoclonal antibodies, and gene and cell therapies.

“The biotechnology & pharmaceutical companies segment is projected to register the highest CAGR during the forecast period”
Based on end users, the global lab automation market is segmented hospital & diagnostic laboratories, biotechnology & pharmaceutical companies, research & academic institutes, forensic laboratories, environmental & testing laboratories, and the food & beverage industry. By end users, Biotechnology & pharmaceutical companies segment is projected to register the highest CAGR during the forecast period. Increasing pressure on pharmaceutical companies to develop new and effective drugs has led to a higher demand for automating laboratory processes and reducing the time spent by researchers on routine and repetitive tasks. Adopting lab automation in this process helps reduce the time and costs involved in drug development, as it increases the speed and accuracy of tests by reducing false positives and negatives.

“The market in the North America region is expected to hold significant market share for lab automation in 2022.”
The lab automation market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for lab automation in 2022. Diagnostic testing is also on the rise in the region due to the higher penetration of healthcare facilities and growing health awareness. With the increasing geriatric population and the rising prevalence of lifestyle diseases, there has been a significant rise in the demand for diagnostics and therapeutics. To cater to this demand, diagnostic laboratories and research centers are increasingly adopting lab automation solutions.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%

The prominent players in the lab automation market are Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche (Switzerland), PerkinElmer (US), Eppendorf (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), bioMérieux (France), Endress+Hauser Group (Switzerland), Hamilton Company (US), Gilson (US), BMG Labtech (Germany), Aurora Biomed (Canada), Peak Analysis & Automation (UK), Formulatrix (US), QIAGEN (Germany) and Hudson Robotics (US) amiong others.
Research Coverage
This report studies the lab automation market based on product, application, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lab automation market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the lab automation market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the lab automation market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（application drug）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（application drug）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?